التفاصيل البيبلوغرافية
| العنوان: |
Antiretroviral Drug Repositioning for Glioblastoma. |
| المؤلفون: |
Rivas, Sarah R., Mendez Valdez, Mynor J., Chandar, Jay S., Desgraves, Jelisah F., Lu, Victor M., Ampie, Leo, Singh, Eric B., Seetharam, Deepa, Ramsoomair, Christian K., Hudson, Anna, Ingle, Shreya M., Govindarajan, Vaidya, Doucet-O'Hare, Tara T., DeMarino, Catherine, Heiss, John D., Nath, Avindra, Shah, Ashish H. |
| المصدر: |
Cancers; May2024, Vol. 16 Issue 9, p1754, 13p |
| مصطلحات موضوعية: |
THERAPEUTIC use of protease inhibitors, IN vitro studies, ANTIRETROVIRAL agents, GLIOMAS, PATIENT safety, RESEARCH funding, CELL proliferation, TREATMENT effectiveness, DRUG repositioning, ADJUVANT chemotherapy, BIOINFORMATICS, GENE expression, CELL lines, REVERSE transcriptase inhibitors, DRUG efficacy, CELL survival, STEM cells |
| مستخلص: |
Simple Summary: The use of antiretroviral therapy has shown promising antineoplastic effects in multiple cancers; however, its efficacy in glioblastoma is unknown. We conducted an unbiased screen of 16 antiretroviral medications in 40 glioma cell lines and validated their efficacy in patient-derived glioma neurospheres and established cell lines. Our study provides the first mechanistic and functional insight into the utility of drug repurposing for malignant gliomas, which supports the current literature. Given their safety profile, preclinical efficacy, and neuropenetrance, antiretroviral therapy may be a promising adjuvant treatment for glioblastoma. Outcomes for glioblastoma (GBM) remain poor despite standard-of-care treatments including surgical resection, radiation, and chemotherapy. Intratumoral heterogeneity contributes to treatment resistance and poor prognosis, thus demanding novel therapeutic approaches. Drug repositioning studies on antiretroviral therapy (ART) have shown promising potent antineoplastic effects in multiple cancers; however, its efficacy in GBM remains unclear. To better understand the pleiotropic anticancer effects of ART on GBM, we conducted a comprehensive drug repurposing analysis of ART in GBM to highlight its utility in translational neuro-oncology. To uncover the anticancer role of ART in GBM, we conducted a comprehensive bioinformatic and in vitro screen of antiretrovirals against glioblastoma. Using the DepMap repository and reversal of gene expression score, we conducted an unbiased screen of 16 antiretrovirals in 40 glioma cell lines to identify promising candidates for GBM drug repositioning. We utilized patient-derived neurospheres and glioma cell lines to assess neurosphere viability, proliferation, and stemness. Our in silico screen revealed that several ART drugs including reverse transcriptase inhibitors (RTIs) and protease inhibitors (PIs) demonstrated marked anti-glioma activity with the capability of reversing the GBM disease signature. RTIs effectively decreased cell viability, GBM stem cell markers, and proliferation. Our study provides mechanistic and functional insight into the utility of ART repurposing for malignant gliomas, which supports the current literature. Given their safety profile, preclinical efficacy, and neuropenetrance, ARTs may be a promising adjuvant treatment for GBM. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder